Her academic background, coupled with extensive practical experience, has made her highly effective in the field of translational medicine, significantly advancing the translation of scientific findings in cardiovascular and metabolic diseases into clinical applications
PMID 28365374
Systematic monitoring throughout the GLP-1 journey enables clinicians to assess therapeutic response, identify adverse effects early, and make evidence-based adjustments to optimize outcomes
Biochemical Society transactions 10 , 7879 (1982)
ED, such as BN and BED, as well as FA, were associated with an increased eating rate, increased energy intake, as well as addictive reward responses, and these physiological changes were similar to the types of changes that were seen in the case of SUD (91, 122126)
The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
